These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19775638)

  • 1. New agents in metastatic prostate cancer.
    Fizazi K; Massard C
    Eur J Cancer; 2009 Sep; 45 Suppl 1():379-80. PubMed ID: 19775638
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complete androgen blockage in the treatment of metastatic prostate cancer].
    Matzkin H; Braf Z
    Harefuah; 1994 Mar; 126(5):260-3. PubMed ID: 8188104
    [No Abstract]   [Full Text] [Related]  

  • 3. Castration-refractory prostate cancer: New drugs in the pipeline.
    Schrijvers D; Van Erps P; Cortvriend J
    Adv Ther; 2010 May; 27(5):285-96. PubMed ID: 20532721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drug development in metastatic prostate cancer.
    Armstrong AJ; George DJ
    Urol Oncol; 2008; 26(4):430-7. PubMed ID: 18593623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New perspectives in the drug therapy of hormone-resistant prostate cancer].
    Vorob'ev NA; Nosov AK; Vorob'ev AV; Moiseenko VM
    Vopr Onkol; 2010; 56(6):645-53. PubMed ID: 21395118
    [No Abstract]   [Full Text] [Related]  

  • 6. [New hormonal treatments of metastatic prostatic cancer. Review of the literature].
    Dubost JJ; Sauvezie B; Ristori JM; Thevenet JP; Rampon S
    Rev Rhum Mal Osteoartic; 1985 Oct; 52(10):577-85. PubMed ID: 3909364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monotherapy with casodex at a dose of 150 mg--a new method of hormonal treatment of disseminated prostatic cancer].
    Rusakov IG; Alekseev BIa
    Urologiia; 2002; (5):23-6. PubMed ID: 12402771
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of prostate cancer. Part 3: metastatic disease.
    Shah J; Khaksar SJ; Sooriakumaran P
    Expert Rev Anticancer Ther; 2006 May; 6(5):813-21. PubMed ID: 16759171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Principles for the conservative drug therapy treatment of prostate cancer].
    Hofmann W
    Z Urol Nephrol; 1981 Sep; 74(9):697-704. PubMed ID: 7314992
    [No Abstract]   [Full Text] [Related]  

  • 10. New drugs in prostate cancer.
    Armstrong AJ; Carducci MA
    Curr Opin Urol; 2006 May; 16(3):138-45. PubMed ID: 16679849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castration-resistant prostate cancer--hormone therapy redux.
    Tolcher AW; Cooper J
    J Clin Oncol; 2010 Mar; 28(9):1447-9. PubMed ID: 20159817
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic therapeutic strategies for prostate cancer.
    Nelson WG
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):619-21. PubMed ID: 16167046
    [No Abstract]   [Full Text] [Related]  

  • 13. New drugs in the management of advanced prostate cancer.
    Kelly WK
    Cancer J; 2008; 14(1):10. PubMed ID: 18303476
    [No Abstract]   [Full Text] [Related]  

  • 14. [Castration of prostate cancer patients and cognition].
    Portin R; Koskinen A; Helenius H; Nurmi M; Salminen E
    Duodecim; 2005; 121(16):1784-5. PubMed ID: 16268226
    [No Abstract]   [Full Text] [Related]  

  • 15. PSA response to thalidomide in patients with advanced prostate cancer.
    Leibowitz R; Tucker SJ
    Oncology (Williston Park); 2002 Sep; 16(9):1146, 1148. PubMed ID: 12380944
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the treatment of metastatic prostate cancer by testicular ablation or total androgen blockade. The Canadian Anandron Study Group.
    Cancer Treat Res; 1992; 59():29-40. PubMed ID: 1347692
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel concepts in androgen receptor blockade.
    Hsieh AC; Ryan CJ
    Cancer J; 2008; 14(1):11-4. PubMed ID: 18303477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metastatic cancer of the prostate: course, diagnosis and therapeutic management].
    Wisard M; Gabellon S
    Rev Med Suisse Romande; 1995 Mar; 115(3):241-7. PubMed ID: 7777765
    [No Abstract]   [Full Text] [Related]  

  • 19. New drug for prostate cancer.
    Eur J Cancer Care (Engl); 2001 Jun; 10(2):79-80. PubMed ID: 11829051
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of hormonotherapy in the treatment of metastatic prostate cancer].
    Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S332-7. PubMed ID: 19070812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.